You are here
- Home
- Therapy Areas
- Neuroscience
Epidemiology Study to Assess the Safety of a New Slow-release Form of Seroquel (Quetiapine) in the Post-marketing Phase in the UK
- Disease
- schizophrenia
- Drug Name
- Seroquel
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Jan 18, 1971
- Study Name
- GPRD SeroquelS
- Study Id
- D1444C00006
- ClinicalTrials.gov ID
- NCT01447082
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
